DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Quinapril (Quinapril Hydrochloride) - Summary

 

-- advertisement --

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, quinapril hydrochloride tablets, USP should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.

 

QUINAPRIL SUMMARY

QUINAPRIL HYDROCHLORIDE TABLETS, USP

Quinapril hydrochloride is the hydrochloride salt of quinapril, the ethyl ester of a non-sulfhydryl, angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.

Hypertension

Quinapril hydrochloride tablets are indicated for the treatment of hypertension. Quinapril hydrochloride tablets may be used alone or in combination with thiazide diuretics .

Heart Failure

Quinapril hydrochloride tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics and/or digitalis.

In using quinapril hydrochloride tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease. Available data are insufficient to show that quinapril hydrochloride does not have a similar risk (see WARNINGS).

Angioedema in black patients

Black patients receiving ACE inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non-blacks. It should also be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks.

QUINAPRIL NEWS HIGHLIGHTS

Published Studies Related to Quinapril

Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis. [2008.06]

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. [2007.11]

The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. [2007.09]

Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial. [2007.02]

Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies. [2007]

more>>

Clinical Trials Related to Quinapril

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension [Completed]

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients [Terminated]

Fasting Study of Quinapril Hydrochloride Tablets 40 mg and AccuprilŽ Tablets 40 mg [Completed]

Food Study of Quinapril Hydrochloride Tablets 40 mg and AccuprilŽ Tablets 40 mg [Completed]

Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women [Completed]

more>>

Page last updated: 2008-06-22

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008